Metagenomics Market size to Reach USD 7.41 Billion by 2031 Amid Rising Clinical Adoption and AI-Integrated Sequencing Platforms

Mordor Intelligence has published a new report on the metagenomics market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Metagenomics Market Overview

According to Mordor Intelligence, the metagenomics market size [https://www.mordorintelligence.com/industry-reports/metagenomics-market?utm_source=abnewswire] is projected to grow from USD 3.28 billion in 2025 to USD 3.76 billion in 2026, reaching USD 7.41 billion by 2031, at a CAGR of 14.57% during the forecast period. The rising use of artificial intelligence in sequencing workflows and the continued decline in whole-genome sequencing costs are shaping the current metagenomics market growth trajectory.

The metagenomics industry has transitioned from being primarily research-driven to becoming increasingly relevant in clinical diagnostics, environmental monitoring, and pharmaceutical discovery. Faster pathogen detection, improvements in sequencing chemistry, and government-backed microbiome programs are strengthening the metagenomics market forecast across regions.

Key Metagenomics Market Trends Driving Industry Expansion

AI Integration in Sequencing and Data Interpretation

One of the most visible metagenomics market trends is the integration of AI into sequencing and bioinformatics platforms. AI-driven analytics significantly reduce pathogen identification time, allowing clinical laboratories to move from days-long processes to near real-time detection. This capability is increasing the clinical relevance of the metagenomics industry and supporting wider healthcare adoption.

Declining Cost of High-Throughput Sequencing

The steady reduction in sequencing costs continues to influence the metagenomics market size. Affordable genome sequencing has expanded accessibility beyond elite research institutions to mid-sized laboratories and environmental testing facilities. Budget allocations are gradually shifting from capital-intensive instruments toward bioinformatics expertise and managed sequencing services.

Expansion of Environmental Monitoring Applications

Environmental applications are emerging as a fast-growing segment within the metagenomics industry. Governments and corporations increasingly use microbial community profiling for wastewater surveillance, oil spill management, agricultural soil testing, and climate-related studies. These expanding use cases are reshaping the long-term metagenomics market forecast, especially outside traditional healthcare settings.

Advancements in Long-Read Sequencing

Long-read sequencing platforms are gaining attention for their ability to deliver strain-level resolution. These platforms help detect antimicrobial resistance genes and structural variations that short-read systems may miss. As a result, third-generation sequencing technologies are influencing future metagenomics market trends by enabling deeper microbial analysis across clinical and environmental domains.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/metagenomics-market?utm_source=abnewswire

Metagenomics Market Segmentation Analysis

By Product

*
Kits and reagents

*
Sequencing and data analytics services

*
Instruments and consumables

By Technology

*
Sequencing-driven metagenomics

*
Function-driven metagenomics

*
Amplicon-based approaches

*
Third-generation long-read sequencing

By Application

*
Human health

*
Environmental monitoring

*
Agricultural and food testing

*
Drug discovery and pharmaceutical research

By End User

*
Academic and research institutions

*
Clinical diagnostic laboratories

*
Pharmaceutical and biotechnology companies

*
Contract research organizations

*
Environmental and food testing laboratories

By Geography

*
North America

*
Europe

*
Asia Pacific

*
Middle East and Africa

*
South America

Competitive Landscape in the Metagenomics Industry

The metagenomics market is moderately concentrated, with established sequencing providers facing competition from emerging AI-focused entrants and cost-disruptive platforms. Competitive strategies include acquisitions, cloud-based analytics partnerships, and expansion of sequencing-as-a-service models.

Key players operating in the metagenomics industry include:

*
Illumina, Inc.

*
PerkinElmer Inc.

*
QIAGEN N.V.

*
F. Hoffmann-La Roche Ltd

*
Novogene Co., Ltd

Explore more insights on metagenomics competitive landscape: https://www.mordorintelligence.com/industry-reports/metagenomics-market/companies?utm_source=abnewswire

Conclusion

The metagenomics market is entering a phase of wider clinical acceptance and diversified application. Falling sequencing costs, AI-powered bioinformatics, and rising environmental surveillance are reinforcing long-term metagenomics market growth.

While challenges remain, including high total workflow costs and shortages of skilled bioinformaticians, outsourcing models and cloud-based analysis platforms are helping bridge capability gaps. The metagenomics industry is gradually expanding beyond research laboratories into routine diagnostics, pharmaceutical pipelines, and environmental compliance frameworks.

Overall, the evolving balance between products and services, the integration of AI, and expanding end-user adoption will continue to define the competitive direction and metagenomics market trends over the coming years.

Industry Related Reports

Gel Permeation Chromatography Market:

The Gel Permeation Chromatography Market is segmented by product type, technology, end user, application, and geography, with forecasts provided in USD. Growth is driven by increasing demand for polymer characterisation, rising biopharmaceutical applications, and greater adoption of automated and high-temperature GPC systems.

Get more insights: https://www.mordorintelligence.com/industry-reports/gel-permeation-chromatography-market?utm_source=abnewswire

Adult Stem Cells Market size:

The Adult Stem Cells Market is estimated at USD 14.07 billion in 2026 and is projected to reach USD 23.27 billion by 2031, growing at a CAGR of 10.58% during 2026-2031. Expansion is supported by rising regenerative medicine research, broader therapeutic use, and increasing investments from biotech and pharmaceutical companies.

Get more insights: https://www.mordorintelligence.com/industry-reports/adult-stem-cells-market?utm_source=abnewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=metagenomics-market-size-to-reach-usd-741-billion-by-2031-amid-rising-clinical-adoption-and-aiintegrated-sequencing-platforms]
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.